2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs 

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2675
  



  

  
Submitter : 
  

  
Ms. Sarah Vogt
  

  
Date & Time: 
  

  
02/16/2006 02:02:38
  



  

  
Organization : 
  

  
Ms. Sarah Vogt
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 The FDA should not close down the bioidentical option of healthcare unless there is another safe, proven, viable option to replace it.